Society for Participatory Medicine
JANUARY 27, 2022
But returning to Erin Moore’s point, how do we get researchers, clinicians, and industry engaged to listen to patients in clinical trial design, pharma/biotech drug development and health tech capability? And I propose a toast: “To stop talking about involving patients and actually do it in 2022. Connect with her at [link].
Society for Participatory Medicine
FEBRUARY 1, 2023
Flash back to my article for the Society for Participatory Medicine last year: Let’s Save the Date and Make Patient Engagement Official in 2022. The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
DrKumo Remote Patient Monitoring
APRIL 12, 2022
Though the drug metformin (a biguanide formed by the fusion of two guanidines) was developed in 1922 by Wermer and Bell, it was the efforts of the French physician Jean Sterne that paved the way for the use of metformin as a glucose-lowering drug. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022.
DrKumo Remote Patient Monitoring
FEBRUARY 29, 2024
The Explosive Growth of Generative AI in Healthcare Market by 2032 According to a report from finance.yahoo.com, the global market for generative AI in healthcare, which was estimated at $1,070 million in 2022, is forecasted to surge to around $21,740 million by the year 2032. What are the benefits of AI in drug development?
Xealth
JUNE 27, 2023
Its interest in DTx exists specifically in remote patient monitoring because of the potential to provide valuable insights throughout drug development life cycles. Several big players have joined the DTA, which doubled in membership in 2022. Big Pharma is driving much of the speculation. They include Astellas Pharma Inc.,
Expert insights. Personalized for you.
107 
Let's personalize your content